Abcam PLC is a leading supplier of life science research tools and reagents. The company was founded in 1998 by Jonathan Milner and David Cleevely in Cambridge, United Kingdom. It initially started as a spin-off from the University of Cambridge, with the aim of providing high-quality antibodies to researchers worldwide. Over the years, Abcam has grown to become a global player in the life sciences industry expanding its operations with offices and distribution centers in multiple countries, including the United States, China, Japan, and Germany, among others.
Abcam's core business is the production and distribution of antibodies and other research tools used by scientists and researchers in various fields, including cancer research, neuroscience, cell biology, and immunology. The company's product portfolio includes a vast range of high-quality antibodies, proteins, assays, and other reagents that support life science research and discovery.
The company places significant emphasis on validation and characterization of its products, ensuring that researchers can rely on the performance and specificity of the reagents they purchase. Abcam's dedication to quality has earned it a strong reputation in the scientific community.
Moreover, Abcam maintains an extensive online presence through its user-friendly website, allowing researchers to access its products and resources easily. The company provides valuable technical support and scientific resources to help researchers make informed decisions about their experimental design and methodology.
Abcam continues to expand its product offerings and strategic partnerships, further solidifying its position as a leading supplier of life science research tools worldwide. The company's contributions to the scientific community play a crucial role in advancing knowledge and understanding in various disciplines, ultimately contributing to advancements in medicine and healthcare.